Skip to main content
. 2021 Oct 29;12:760708. doi: 10.3389/fimmu.2021.760708

Figure 2.

Figure 2

Kaplan-Meier curves for infection-free survival within the first 12 months after the first rituximab administration in patients with nephritic (blue line) and nephrotic (red line) syndrome.